We are in a constant battle with sickness and disease in this world. But, we are very lucky to be living in a world with modern medicine that is constantly developing new ways and methods to treat, prevent, and destroy viruses, diseases, and sicknesses all around us. Malaria is a disease that has spread throughout the world, killing over a million people each year (unicef.org). With many people working on how to prevent, treat, and destroy the parasite, they have done so with the work of drug-delivering drones and even genetically engineered mosquitoes that are unable to carry the parasite. Amy Maxmen, an award-winning science journalist explains that amid so much technology, a more “old fashioned” approach of combating the disease seems to be saving tens-of-thousands of lives.
Seasonal
malaria chemoprevention involves “giving children a dose of antimalarial drugs
once each month in the rainy season to prevent the disease in hard-hit regions.” Since the initiation of
this strategy in the last few years we have seen incredible results in saving
lives and reducing the number of malaria cases. But, this isn’t the first time
this strategy has been put to use. In the 1950s, the use of chemoprevention was
put into play but was not a good long-term solution due to drug resistance from
the widespread use of malaria drugs. Years later in the year 2000
malariologists saw that almost a million people - mostly children - were dying
each year from malaria. So, they revisited the chemopreventional approach and
found that “between 2002 and 2012, clinical trials conducted in West Africa
suggested that combinations of older malaria drugs had the power to prevent 8.8
million cases and 80,000 deaths every year if implemented solely during the
rainy season, when the disease spikes (nature.com).” After implementing the
chemoprevention “they are seeing the same level of efficacy against malaria
that we saw in clinical trials and reducing hospital admissions (nature.com).”
The combination of three older
malaria drugs, (sulphadoxine, pyrimethamine and amodiaquine) is what has saved
tens-of-thousands of lives since. Using three older drugs provides the main cure,
artemisinin, to remain effective if tolerance or resistance to the other drugs
came to be.
Sadly, this is no long-term solution
to the problem. Scientists have already seen a drug resistance in parasites and
are working to “hit the disease hard and fast” (nature.com) in order to
continually decrease the amount of cases and deaths of malaria in Africa for
the long-term.
Malaria researchers estimated that
chemoprevention has averted about 6 million cases and 40,000 deaths in 2015 and
2016 in Chad, Niger, and other Sub-Saharan African countries. Also, they said
that “malaria prevalence was reduced by 65% in children under age 5 who were
treated… in the Malian district of Kita.” (nature.com) These results are
promising and many people are working very hard to keep this momentum going to
continue to save lives. Since the results, the American Society of Tropical
Medicine and Hygiene (ASTMH) is planning to help fund the chemoprevention
program in eight more countries next year.
This article was very informative and
eye-opening for me. I had no idea how many people died of malaria and I had no
idea it was such a large problem. This is important to me because it’s not only
making a new scientific discovery but saving thousands of lives and making
their lives better. Through the evolution and advancements of science we can do
amazing things in technology and medicine and this give me hope for a safer,
and healthier world.
Resources:
http://www.nature.com/news/resurrected-malaria-strategy-saves-thousands-of-lives-in-africa-1.22982
https://www.unicef.org/health/files/health_africamalaria.pdf
Resources:
http://www.nature.com/news/resurrected-malaria-strategy-saves-thousands-of-lives-in-africa-1.22982
https://www.unicef.org/health/files/health_africamalaria.pdf

No comments:
Post a Comment